Ten-year performance of Influenzanet: ILI time series, risks, vaccine effects, and care-seeking behaviour

Epidemics

Volumn 13, Issue , 2015, Pages 28-36

  van Noort, Sander P ^a   Codeço, Cláudia T ^a,b   Koppeschaar, Carl E ^c   van Ranst, Marc ^d   Paolotti, Daniela ^e   Gomes, M Gabriela M ^a  

^a INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c De Grote Griepmeting Science in Action   (Netherlands)

^d REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^e ISI FOUNDATION   (Italy)

Author keywords

Influenza like illness; Risk factors; Syndromic surveillance; Time series; Vaccine effectiveness

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CYCLING; DEMOGRAPHY; DISEASE SURVEILLANCE; EPIDEMIC; EUROPE; FEMALE; FLU LIKE SYNDROME; HELP SEEKING BEHAVIOR; HUMAN; INCIDENCE; INFLUENZA A (H1N1); LOCOMOTION; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MIDDLE AGED; MONITORING; PET ANIMAL; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING; SPORT; TRAFFIC AND TRANSPORT; VACCINATION; WALKING; ADOLESCENT; AGE; ANIMAL; HEALTH BEHAVIOR; INFLUENZA, HUMAN; RISK; YOUNG ADULT;

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANIMALS; CHRONIC DISEASE; EUROPE; FEMALE; HEALTH BEHAVIOR; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PETS; RISK; RISK FACTORS; YOUNG ADULT;

EID: 84955490579     PISSN: 17554365     EISSN: 18780067     Source Type: Journal    
DOI: 10.1016/j.epidem.2015.05.001     Document Type: Article

References (47)

1. Aguilera J.F., Paget W.J., Mosnier A., Heijnen M.L., Uphoff H., et al. Heterogeneous case definitions used for the surveillance of influenza in Europe. Eur. J. Epidemiol. 2003, 18(8):751-754.
2. Allard R. Use of time-series analysis in infectious disease surveillance. Bull. World Health Organ. 1998, 76(4):327-333.
3. Arcavi L., Benowitz N.L. Cigarette smoking and infection. Arch. Intern. Med. 2004, 164(20):2206-2216.
4. Bajardi P., Paolotti D., Vespignani A., Eames K., Funk S., et al. Association between recruitment methods and attrition in Internet-based studies. PLoS ONE 2014, 9(12):e114925.
5. Belongia E.A., Kieke B.A., Donahue J.G., Greenlee R.T., Balish A., et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J. Infect. Dis. 2009, 199(2):159-167.
6. Bloom R.M., Buckeridge D.L., Cheng K.E. Finding leading indicators for disease outbreaks: filtering, cross-correlation, and caveats. J. Am. Med. Inform. Assoc. 2007, 14(1):76-85.
7. Bridges C.B., Thompson W.W., Meltzer M.I., Reeve G.R., Talamonti W.J., et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. J. Am. Med. Inform. Assoc. 2000, 284(13):1655-1663.
8. Butler D. Disease surveillance needs a revolution. Nature 2006, 440(7080):6-7.
9. Cantarelli P., Debin M., Turbelin C., Poletto C., Blanchon T., et al. The representativeness of a European multi-center network for influenza-like-illness participatory surveillance. BMC Public Health 2014, 14:984.
10. Cauchemez S., Donnelly C.A., Reed C., Ghani A.C., Fraser C., et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N. Engl. J. Med. 2009, 361(27):2619-2627.
11. Chretien J.P., Burkom H.S., Sedyaningsih E.R., Larasati R.P., Lescano A.G., et al. Syndromic surveillance: adapting innovations to developing settings. PLoS Med. 2008, 5(3):e72.
12. Cooper D.L., Smith G.E., Regan M., Large S., Groenewegen P.P. Tracking the spatial diffusion of influenza and norovirus using telehealth data: a spatiotemporal analysis of syndromic data. BMC Med. 2008, 6:16.
13. Debin M., Colizza V., Blanchon T., Hanslik T., Turbelin C., Falchi A. Effectiveness of 2012-2013 influenza vaccine against influenza-like illness in general population: estimation in a French web-based cohort. Hum. Vaccine Immunother. 2014, 10(3):536-543.
14. Demicheli V., Jefferson T., Al-Ansary L.A., Ferroni E., Rivetti A., et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst. Rev. 2009, 3.
15. Eames K.T., Brooks-Pollock E., Paolotti D., Perosa M., Gioannini C., Edmunds W.J. Rapid assessment of influenza vaccine effectiveness: analysis of an internet-based cohort. Epidemiol. Infect. 2012, 140(7):1309-1315.
16. Eames K.T.D., Tilston N.L., Brooks-Pollock E., Edmunds W.J. Measured dynamic social contact patterns explain the spread of H1N1v influenza. PLoS Comput. Biol. 2012, 8(3):e1002425.
17. Friesema I.H.M., Koppeschaar C.E., Donker G.A., Dijkstra F., van Noort S.P., et al. Internet-based monitoring of influenza-like illness in the general population: experience of five influenza seasons in the Netherlands. Vaccine 2009, 27(45):6353-6357.
18. Ginsberg J., Mohebbi M.H., Patel R.S., Brammer L., Smolinski M.S., et al. Detecting influenza epidemics using search engine query data. Nature 2009, 457(7232):1012-1014.
19. Gordon A., Ortega O., Kuan G., Reingold A., Saborio S., et al. Prevalence and seasonality of influenza-like illness in children, Nicaragua, 2005-2007. Emerg. Infect. Dis. 2009, 15(3):408-414.
20. Gupta V., Earl D.J., Deem M.W. Quantifying influenza vaccine efficacy and antigenic distance. Vaccine 2006, 24(18):3881-3888.
21. Henning K.J. What is syndromic surveillance?. MMWR Morb. Mortal. Wkly. Rep. 2004, 53(Suppl.):5-11.
22. Hyndman R., Athanasopoulos G. Forecasting: Principles and Practice 2014, http://otexts.org/fpp/ (accessed April 2014).
23. Irwin D.E., Weatherby L.B., Huang W.Y., Rosenberg D.M., Cook S.F., et al. Impact of patient characteristics on the risk of influenza/ILI-related complications. BMC Health Serv. Res. 2001, 1(1):8.
24. Jackson L.A., Jackson M.L., Nelson J.C., Neuzil K.M., Weiss N.S. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int. J. Epidemiol. 2006, 35(2):337-344.
25. Jefferson T., Di Pietrantonj C., Al-Ansary L.A., Ferroni E., Thorning S., et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst. Rev. 2010, (2):CD004876.
26. Jin H., Zhou H., Liu H., Chan W., Adhikary L., Mahmood K., Lee M.S., Kemble G. Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology 2005, 336(1):113-119.
27. Keramarou M., Cottrell S., Evans M.R., Moore C., Stiff R.E., et al. Two waves of pandemic influenza A(H1N1) 2009 in Wales-the possible impact of media coverage on consultation rates, April-December 2009. Euro Surveill. 2011, 16(3).
28. Lazarus R., Kleinman K.P., Dashevsky I., DeMaria A., Platt R. Using automated medical records for rapid identification of illness syndromes (syndromic surveillance): the example of lower respiratory infection. BMC Public Health 2001, 1:9.
29. Lipsitch M., Hayden F.G., Cowling B.J., Leung G.M. How to maintain surveillance for novel influenza a H1N1 when there are too many cases to count. Lancet 2009, 374(9696):1209-1211.
30. Mandl K.D., Overhage J.M., Wagner M.M., Lober W.B., Sebastiani P., et al. Implementing syndromic surveillance: a practical guide informed by the early experience. J. Am. Med. Inform. Assoc. 2004, 11(2):141-150.
31. Marquet R.L., Bartelds A.I.M., van Noort S.P., Koppeschaar C.E., Paget J., et al. Internet-based monitoring of influenza-like illness (ILI) in the general population of the Netherlands during the 2003-2004 influenza season. BMC Public Health 2006, 6:242.
32. Merk H., Kuhlmann-Berenzon S., Bexelius C., Sandin S., Litton J.E., et al. The validity of self-initiated, event-driven infectious disease reporting in general population cohorts. PLOS ONE 2013, 8(4):e61644.
33. Monto A.S. Occurrence of respiratory virus: time, place and person. Pediatr. Infect. Dis. J. 2004, 23(1 Suppl.):S58-S64.
34. Monto A.S., Ross H. Acute respiratory illness in the community: effect of family composition, smoking, and chronic symptoms. Br. J. Prev. Soc. Med. 1977, 31(2):101-108.
35. O'Brien R.M. A caution regarding rules of thumb for variance inflation factors. Qual. Quant. 2007, 41(5):673-690. ISSN 0033-5177.
36. Paolotti D., Carnahan A., Colizza V., Eames K., Edmunds J., et al. Web-based participatory surveillance of infectious diseases: the Influenzanet participatory surveillance experience. Clin. Microbiol. Infect. 2014, 20(1):17-21.
37. Patterson-Lomba O., van Noort S.P., Cowling B.J., Wallinga J., Gomes M.G.M., et al. Utilizing syndromic surveillance data for estimating levels of influenza circulation. Am. J. Epidemiol. 2014, 179(11):1394-1401.
38. R Development Core Team R: A Language and Environment for Statistical Computing. 2014, R Foundation for Statistical Computing, Vienna, Austria.
39. Rehn M., Carnahan A., Merk H., ouml K., hlmann-Berenzon S., Galanis I., et al. Evaluation of an Internet-based monitoring system for influenza-like illness in Sweden. PLoS ONE 2014, 9(5):e96740.
40. Reis B.Y., Kohane I.S., Mandl K.D. An epidemiological network model for disease outbreak detection. PLoS Med 2007, 4(6):e210.
41. Smolderen K.G.E., Vingerhoets A.J.J.M., Croon M.A., Denollet J. Personality, psychological stress, and self-reported influenza symptomatology. BMC Public Health 2007, 7:339.
42. van Noort S.P., Muehlen M., de Andrade H.R., Koppeschaar C., Lourenço J.M.L., et al. Gripenet: an internet-based system to monitor influenza-like illness uniformly across Europe. Euro Surveill. 2007, 12(7):E5-E6.
43. van Noort S.P., Águas R., Ballesteros S., Gomes M.G.M. The role of weather on the relation between influenza and influenza-like illness. J. Theor. Biol. 2012, 298:131-137.
44. van Noort S.P. Participatory Surveillance and Mathematical Models in Epidemiologic Research: Successes and Challenges 2014, (PhD thesis), Universidade Nova de Lisboa.
45. Vandendijck Y., Faes C., Hens N. Eight years of the great influenza survey to monitor influenza-like illness in Flanders. PLOS ONE 2013, 8(5):e64156.
46. Viboud C., Boëlle P.Y., Cauchemez S., Lavenu A., Valleron A.J., et al. Risk factors of influenza transmission in households. Br. J. Gen. Pract. 2004, 54(506):684-689.
47. van den Wijngaard C., van Asten L., van Pelt W., Nagelkerke N.J.D., Verheij R., et al. Validation of syndromic surveillance for respiratory pathogen activity. Emerg. Infect. Dis. 2008, 14(6):917-925.